July 7th 2020 IDA Ireland welcomes today’s announcement that MSD has acquired the Takeda biologics facility in Dunboyne, Co. Meath.
IDA Ireland assisted Takeda and its representatives in marketing the Dunboyne facility since the company announced its intention to sell in January of this year.
Merck & Co., Inc. (MSD) is a global pharmaceutical company with five different facilities in Ireland; in Bandon, Cork, in Carlow, Ballydine in Tipperary, Swords & Leopardstown Shared Services.
CEO of IDA Ireland, Martin Shanahan said: “This is very welcome news indeed. MSD is a leading global pharmaceutical company with a long track record of successful operations in Ireland. The company is a substantial and valued employer whose commitment to Ireland is evidenced by the significant capital investment it has made over the years in its different sites here. This acquisition will allow MSD to further develop the site and secure the employment of Takeda’s existing staff. It is an excellent outcome.”